Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating interstitial lung disease. Two antifibrotics, pirfenidone and nintedanib, are available for IPF treatment. Pirfenidone is available as 267 mg capsules and, more recently, as 267 mg and 801 mg tablets. The aim of this st...

Full description

Saved in:
Bibliographic Details
Published in:Pulm Ther
Main Authors: Lancaster, Lisa H., Valenzuela, Claudia, Mason, Wendi, Neurohr, Claus, Ripamonti, Elena, Kirchgaessler, Klaus-Uwe, Cottin, Vincent
Format: Artigo
Language:Inglês
Published: Springer Healthcare 2020
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229113/
https://ncbi.nlm.nih.gov/pubmed/32193713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-020-00111-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items